Persistent Asset Partners’s Journey Medical DERM Stock Holding History

Persistent Asset Partners’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.4K	Buy	+10,082	New	+$57.6K	0.02%	364

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Persistent Asset Partners's DERM Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Journey Medical (DERM) in Q2 2026: 10,082 shares worth $71.4K. The stake represents 0.02% of the portfolio and ranks #364 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Persistent Asset Partners held 10,082 shares of Journey Medical worth $71.4K as of Q2 2026.
Journey Medical was a new Persistent Asset Partners position in Q2 2026.
Journey Medical made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #364 holding.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.